SCHEMBL4206255

SCHEMBL4206255

Cc1cccc(C)c1C(C)Oc1ccc(C#N)c(Cl)c1

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
AR P10275 7/20 0.57
MRGPRX4 Q96LA9 1/20 0.43
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SLC22A12 Q96S37 2/20 0.40
LMNA P02545 2/20 0.40
GAA P10253 1/20 0.40
TRPV4 Q9HBA0 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NR3C1 P04150 1/20 0.37
PGR P06401 2/20 0.37
FGFR1 P11362 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13779687 0.85 AR (0.59) ARMRGPRX4ALDH1A1KDM4EL3MBTL1
SCHEMBL4197135 0.81 AR (0.48) ARMRGPRX4ALDH1A1KDM4EL3MBTL1
SCHEMBL4192800 0.80 AR (0.52) ARMRGPRX4ALDH1A1KDM4EL3MBTL1
SCHEMBL177449 0.79 AR (0.53) ARMRGPRX4ALDH1A1KDM4EL3MBTL1
SCHEMBL4198741 0.78 AR (0.51) ARMRGPRX4ALDH1A1KDM4EL3MBTL1
SCHEMBL4207754 0.78 AR (0.69) ARMRGPRX4SLC22A12TRPV4PGR
SCHEMBL27376804 0.75 AR (0.52) ARMRGPRX4ALDH1A1KDM4EL3MBTL1
SCHEMBL4175953 0.72 AR (1.00) ARSLC22A12GAAPGR
SCHEMBL26127201 0.72 AR (0.49) ARMRGPRX4ALDH1A1KDM4ETRPV4
SCHEMBL474005 0.71 AR (0.68) ARSLC22A12TRPV4PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090170886-A1 ANDROGEN MODULATORS PFIZER INC 2009-07-02 US disclosed
US-20090170886-A1 ANDROGEN MODULATORS PFIZER INC 2009-07-02 US disclosed
US-20090170886-A1 ANDROGEN MODULATORS PFIZER INC 2009-07-02 US disclosed
WO-2007017754-A2 ANDROGEN MODULATORS WARNER-LAMBERT COMPANY LLC (US) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170886-A1 ANDROGEN MODULATORS AR, NR5A1, SHBG AR 1/4885MRGPRX4 1139/4885ALDH1A1 774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.